Case Report: The JAK-Inhibitor Ruxolitinib Use in Aicardi-Goutieres Syndrome Due to
Aicardi-Goutières syndrome
JAK-inhibitor
interferonopathies
ruxolitinib
type I interferon
Journal
Frontiers in pediatrics
ISSN: 2296-2360
Titre abrégé: Front Pediatr
Pays: Switzerland
ID NLM: 101615492
Informations de publication
Date de publication:
2021
2021
Historique:
received:
12
07
2021
accepted:
22
09
2021
entrez:
15
11
2021
pubmed:
16
11
2021
medline:
16
11
2021
Statut:
epublish
Résumé
Type I Interferonopathies comprise inherited inflammatory diseases associated with perturbation of the type I IFN response. Use of
Identifiants
pubmed: 34778129
doi: 10.3389/fped.2021.725868
pmc: PMC8578119
doi:
Types de publication
Case Reports
Langues
eng
Pagination
725868Informations de copyright
Copyright © 2021 Cattalini, Galli, Zunica, Ferraro, Carpanelli, Orcesi, Palumbo, Pinelli, Giliani, Fazzi and Badolato.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
N Engl J Med. 2020 Nov 26;383(22):2190-2191
pubmed: 33252884
Curr Rheumatol Rep. 2018 Nov 8;20(12):83
pubmed: 30406861
Autoimmun Rev. 2013 Feb;12(4):506-9
pubmed: 22940555
Neurology. 2018 Feb 6;90(6):289-291
pubmed: 29321238
Am J Med Genet A. 2015 Feb;167A(2):296-312
pubmed: 25604658
J Clin Invest. 2018 Jul 2;128(7):3041-3052
pubmed: 29649002
N Engl J Med. 2020 Sep 3;383(10):986-989
pubmed: 32877590
Nat Genet. 2020 Dec;52(12):1364-1372
pubmed: 33230297
N Engl J Med. 2020 Jan 16;382(3):256-265
pubmed: 31940699
J Clin Immunol. 2016 Oct;36(7):693-9
pubmed: 27539236
Ann Rheum Dis. 2016 Dec;75(12):e76
pubmed: 27811148
Nat Rev Immunol. 2015 Jul;15(7):429-40
pubmed: 26052098
Lancet Neurol. 2013 Dec;12(12):1159-69
pubmed: 24183309
Expert Rev Clin Immunol. 2020 Feb;16(2):189-198
pubmed: 31855085
Ann Rheum Dis. 2019 Mar;78(3):431-433
pubmed: 30282666
Ann N Y Acad Sci. 2011 Nov;1238:91-8
pubmed: 22129056
Rheumatology (Oxford). 2019 Feb 1;58(Suppl 1):i43-i54
pubmed: 30806709
J Exp Med. 2017 May 1;214(5):1547-1555
pubmed: 28420733
Curr Rheumatol Rep. 2018 May 30;20(7):40
pubmed: 29846819